Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin

Molecular Carcinogenesis

Volumn 26, Issue 3, 1999, Pages 150-156

  Rodriguez Puebla, Marcelo L ^a   LaCava, Margaret ^a   Bolontrade, Marcela F ^a   Russell, Jamie ^a   Conti, Claudio J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Papilloma; Ras; Squamous cell carcinoma; Tumor progression; Two stage carcinogenesis

Indexed keywords

GENE PRODUCT; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; ONCOPROTEIN;

ANIMAL MODEL; ARTICLE; CELL CYCLE; FEMALE; GENE EXPRESSION; GENE MUTATION; MOUSE; NONHUMAN; ONCOGENE H RAS; PAPILLOMA; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ALLELES; ANIMALS; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; MICE; MICE, INBRED SENCAR; MUTATION; PAPILLOMA; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS P21(RAS); RNA, MESSENGER; SKIN NEOPLASMS;

ANIMALIA;

EID: 0032724725     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199911)26:3<150::AID-MC3>3.0.CO;2-P     Document Type: Article

References (32)

1. Barbarcid M. Ras genes. Annual Rev Biochem 1987;56: 779-828.
2. Cahill MA. Signalling pathways: Jack of all cascades. Curr Biol 1996;6:16-19.
3. Avruch J, Zhang X, Kyariakis J. Raf meets Ras: Completing the framework of a signal transduction pathway. Trends Biochem Sci 1994;19:279-283.
4. Nakazawa H, Aguelon A, Yamasaki H. Identification and quantification of a carcinogen-induced molecular initiation event in cell transformation. Oncogene 1992;7: 2295-2301.
5. Slaga TJ. Cellular and molecular mechanisms involved in multistage skin carcinogenesis. In: Conti CJ, Slaga TJ, Klein-Szanto AJ, editors. Carcinogenesis, comprehensive survey, Vol. 11. New York: Raven Press; 1989. 1-18.
6. Balmain A, Pragnell I. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 1983;303:72-74.
7. Bizub D, Wood A, Skalka A. Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc Natl Acad Sci USA 1986;83: 6048-6052.
8. Roop D, Lowy D, Tambourin P, et al. An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature 1986;323:822-824.
9. Quintanilla M, Brown K, Ramsden M, Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 1986;322:78-80.
10. Aldaz CM, Conti CJ, Klein-Szanto AJP, Slaga T. Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: Relevance to malignancy. Proc Natl Acad Sci USA 1987;84:2029-2032.
11. Aldaz MC, Trono D, Larcher F, Slaga T, Conti CJ. Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol Carcinog 1989;2:22-26.
12. Rodriguez-Puebla ML, LaCava M, Gimenez-Conti IB, Jonhson DG, Conti CJ. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Oncogene 1998;17:2251-2258.
13. Xu X, Lotan R. Nonisotopic in situ hybridization for the detection of nuclear retinoid receptor transcripts in tissue sections. Methods Mol Biol 1998;89:233-246.
14. van Dierendonck JH, Wijsman JH, Keijzer R, van de Velde CJ, Cornelisse CJ. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. Am J Pathol 1991;138:1165-1172.
15. Fukuda M, Okamura K, Rohrbrach R, Bohm N, Fujita S. Changes in cell population kinetics during epidermal carcinogenesis. Cell and Tissue Kinetics 1978;11: 611-621.
16. Greenhalgh D, Rothnagel J, Quintanilla M, et al. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol Carcinog 1993;7:99-110.
17. Greenhalgh D, Quintanilla M, Orengo C, et al. Cooperation between v-fos and v-rasHA induces autonomous papillomas in transgenic epidermis but not malignant conversion. Cancer Res 1993;53:5071-5075.
18. Leder A, Kuo A, Cardiff R, Sinn E, Leder P. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc Natl Acad Sci USA 1990;87:9178-9182.
19. Spalding J, Momma J, Elwell M, Tennant R. Chemically induced skin carcinogenesis in a transgenic mouse line [TG.AC] carrying a v-Ha-ras gene. Carcinogenesis 1993;14: 1335-1341.
20. Greenhalgh D, Welty D, Player A, Yuspa S. Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma. Proc Natl Acad Sci USA 1990;87:643-647.
21. Balmain A, Ramsden M, Bowden G, Smith J. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 1984;307:658-660.
22. Tofgard R, Roop D, Yuspa S. Proto-oncogene expression during two-stage carcinogenesis in mouse skin. Carcinogenesis 1985;6:655-657.
23. Pelling J, Ernst S, Strawhecker J, Johnson J, Nairn R, Slaga T. Elevated expression of Ha-ras is an early event in two-stage skin carcinogenesis in SENCAR mice. Carcinogenesis 1986; 7:1599-1602.
24. Bianchi A, Aldaz MC, Conti CJ. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. Proc Natl Acad Sci USA 1990;87: 6902-6906.
25. Bremner R, Balmain A. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 1990;61:407-417.
26. Robles AI, Conti CJ. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis 1995;16:781-786.
27. Bianchi AB, Fischer SM, Robles Al, Rinchik EM, Conti CJ. Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 1993;8:1127-1133.
28. Filmus J, Robles AI, Shi W, Wong M, Colombo LL, Conti CJ. Induction of cyclin D1 overexpression by activated ras. Oncogene 1994;9:3627-3633.
29. Winston JT, Coats SR, Wang Y-Z, Pledger WJ. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 1996;12:127-134.
30. Albanese C, Johnson J, Watanave G, et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 1995;270: 23589-23597.
31. Robles AI, Rodriguez-Puebla ML, Glick A, et al. Reduced skin tumor development in Cyclin D1 deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev 1998;12: 2469-2474.
32. Rodriguez-Puebla ML, Robles AI, Conti CJ. Ras activity and cyclin D1 expression: An essential mechanism of mouse skin tumor development. Mol Carcinog 1999;24:1-6.